Top Page
British American Tobacco
(LSE:BATS)
British American Tobacco (BATS) vs. iShares MSCI United Kingdom ETF (EWC)
British American Tobacco Business Overview & Revenue Model
British American Tobacco Earnings Call Summary
British American Tobacco Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.60B | 25.87B | 27.28B | 27.66B | 25.68B | 25.78B |
| Gross Profit | 16.58B | 21.43B | 22.39B | 22.85B | 21.09B | 21.33B |
| EBITDA | 4.85B | 7.74B | 8.83B | 12.29B | 11.67B | 11.70B |
| Net Income | 3.04B | 3.07B | -14.37B | 6.67B | 6.80B | 6.40B |
Balance Sheet | ||||||
| Total Assets | 110.23B | 118.90B | 118.72B | 153.55B | 137.37B | 137.69B |
| Cash, Cash Equivalents and Short-Term Investments | 4.89B | 5.81B | 5.26B | 4.03B | 3.27B | 3.38B |
| Total Debt | 35.21B | 36.95B | 39.73B | 43.14B | 39.66B | 43.97B |
| Total Liabilities | 63.05B | 68.90B | 65.78B | 77.84B | 69.96B | 74.73B |
| Stockholders Equity | 46.87B | 49.64B | 52.57B | 75.37B | 67.10B | 62.67B |
Cash Flow | ||||||
| Free Cash Flow | 7.29B | 9.52B | 10.25B | 9.87B | 9.19B | 9.28B |
| Operating Cash Flow | 7.76B | 10.13B | 10.71B | 10.39B | 9.72B | 9.79B |
| Investing Cash Flow | 766.00M | 1.38B | -296.00M | -705.00M | -1.14B | -783.00M |
| Financing Cash Flow | -9.70B | -10.63B | -9.31B | -8.88B | -8.75B | -7.90B |
British American Tobacco Technical Analysis
British American Tobacco Risk Analysis
British American Tobacco Peers Comparison
British American Tobacco Corporate Events
British American Tobacco has repurchased 111,960 ordinary shares from Goldman Sachs International as part of its ongoing share buyback programme, paying a volume-weighted average price of 4,221.91p per share, and will cancel the shares, leaving 2,179,466,149 ordinary shares in issue with voting rights and 132,988,352 shares held in treasury. The transaction completes the company’s 2025 tranche of its buyback initiative, under which it has repurchased 30,282,076 shares for a total consideration of approximately £1.1bn, underscoring management’s continued commitment to capital returns ahead of the extension of the programme into 2026.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has disclosed a share transaction involving a person closely associated with senior management, in line with regulatory requirements for transparency. The company reported that Julia Wheaton, who is closely associated with Chief Corporate Officer Kingsley Wheaton, sold 17,850 ordinary shares in the group at a price of £42.27 each, for a total consideration of £754,519.50, in an off-venue transaction on 22 December 2025, underscoring ongoing monitoring and reporting of insider-related dealings for investors and regulators.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has continued its share buyback programme, repurchasing 153,353 ordinary shares on 22 December 2025 from Goldman Sachs International at a volume-weighted average price of 4,215.6p per share. The company plans to cancel the repurchased shares, reducing the number of shares in issue with voting rights to 2,179,578,109 and holding 132,988,352 shares in treasury, a move that marginally enhances earnings per share and underscores its ongoing commitment to capital returns for shareholders while providing updated figures for regulatory disclosure purposes.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has repurchased 160,500 of its ordinary shares from Goldman Sachs International on 19 December 2025 as part of its ongoing share buyback programme authorised by shareholders earlier in the year. The company intends to cancel these shares, reducing the number of ordinary shares in issue with voting rights to 2,179,731,462, while holding 132,988,352 shares in treasury, a move that tightens the free float and may enhance earnings per share and capital returns for investors, while also affecting shareholders’ disclosure obligations under UK transparency rules.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has repurchased 159,774 of its own ordinary shares on 18 December 2025 from Goldman Sachs International under its ongoing share buyback programme authorised by shareholders earlier this year, paying a volume‑weighted average price of 4,265.90p per share. The company intends to cancel these shares, reducing the number of shares in issue with voting rights to 2,179,891,962 and maintaining 132,988,352 shares in treasury, a capital management move that marginally enhances earnings per share and may support the share price while affecting shareholders’ disclosure thresholds under UK transparency rules.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco PLC announced the purchase of 145,000 ordinary shares as part of its ongoing share buyback program authorized by shareholders at its April 2025 AGM. The purchased shares will be canceled, reducing the total number of shares in issuance and maintaining its treasury holdings, aligning with strategic initiatives to manage equity structure, potentially impacting shareholder value in the near term.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has repurchased 145,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. This transaction, authorized by shareholders, aims to cancel the purchased shares, reducing the total number of shares in issue and potentially impacting shareholder interests and market dynamics.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced that Karen Guerra, a Non-Executive Director, has been appointed as an Independent Director of Société Bic S.A., a company listed on the Euronext Paris. This appointment could enhance the company’s strategic connections and influence within the European market, potentially impacting its industry positioning and stakeholder relations.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 145,000 ordinary shares as part of its ongoing buyback program. This transaction, conducted through Goldman Sachs International, is part of the company’s strategy to manage its share capital and potentially enhance shareholder value. The repurchased shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder voting rights and interests.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 145,000 of its ordinary shares as part of a buyback program, with the intention to cancel these shares. This transaction, executed through Goldman Sachs International, reflects the company’s ongoing strategy to manage its capital structure and potentially enhance shareholder value. Following the cancellation, the company will have 2,180,485,797 ordinary shares in issue, impacting shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the finalization of its February 2026 dividend payment, which is part of the interim dividend declared for the year ending December 2024. Shareholders on the South Africa branch register will receive dividends in rand, with a conversion rate resulting in 1,356.46111 SA cents per share. The dividend is subject to a 20% South Africa Dividends Tax unless exemptions apply, impacting the net dividend received by shareholders.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 132,000 of its ordinary shares as part of its ongoing buyback program. The shares were bought from Goldman Sachs International and will be canceled, reducing the total number of shares in circulation. This move is part of the company’s strategy to enhance shareholder value and may impact the company’s market positioning by potentially increasing earnings per share.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a change in its Audit Committee, with Non-Executive Director Holly Keller Koeppel stepping down effective December 31, 2025. This change in committee membership is part of the company’s ongoing governance adjustments, which may impact how the company manages its financial oversight and strategic decisions moving forward.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced that Holly Keller Koeppel, a Non-Executive Director, will join Shell plc as a Non-Executive Director starting January 1, 2026. This move highlights the company’s strategic connections with other major corporations and may influence its governance dynamics and stakeholder relations.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a buyback of 140,000 ordinary shares at a volume-weighted average price of 4,343.89 pence per share as part of its ongoing share buyback program. This transaction, conducted through Goldman Sachs International, aims to reduce the number of shares in circulation, potentially enhancing shareholder value and adjusting the company’s capital structure.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 162,749 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. The company intends to cancel these shares, which will result in a reduction of the total number of shares in issue, potentially impacting shareholder interests and market dynamics.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £52.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced an extension of its share buyback programme by up to £1.3 billion for 2026. This move aims to reduce the company’s share capital, with the repurchased shares being cancelled. The buyback will be executed independently by UBS AG London Branch during a closed period, adhering to regulatory guidelines. This strategic decision reflects the company’s commitment to enhancing shareholder value and optimizing its capital structure.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £52.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 110,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. This transaction, conducted under the authority granted by shareholders, is aimed at reducing the number of shares in circulation, thereby potentially increasing the value of remaining shares and enhancing shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £4733.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced a £1.3 billion share buy-back and reaffirmed its guidance for 2026, expecting a 2% growth in revenue and adjusted profit for FY25. The company is experiencing strong momentum in the U.S. market, driven by its combustibles and Velo Plus products, and is seeing improvements in its Vuse vapour products due to increased enforcement against illicit products. The company is focused on accelerating growth in its New Category segment, with Velo showing strong performance globally. Despite challenges in certain regions, BAT remains confident in its mid-term growth targets and is committed to reducing leverage and delivering shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £4733.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has announced the purchase of 110,000 of its ordinary shares as part of its ongoing buyback program, which was approved by shareholders. The shares were acquired from Goldman Sachs International and will be canceled, reducing the total number of shares in issue. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value. The transaction may also affect shareholders’ notification requirements under the FCA’s rules.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £4733.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 110,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. The purchased shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder voting rights and interest notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £52.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has completed the block trade of 187.5 million shares in ITC Hotels, representing 9% of the hotel’s share capital, through an accelerated bookbuild process. The transaction generated net proceeds of INR 38.2 billion, which will be used to achieve BAT’s target leverage ratio by the end of 2026. Following this transaction, BAT retains a 6.3% stake in ITC Hotels, indicating a strategic move to optimize its financial position while maintaining a presence in the hospitality sector.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £52.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced that several of its executive directors and managerial staff have purchased ordinary shares in the company as part of the Partnership Share Scheme, a HMRC approved Share Incentive Plan. This move reflects the confidence of the company’s leadership in its future prospects and aligns their interests with those of the shareholders, potentially strengthening stakeholder trust and market positioning.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced plans to sell between 7% and 15.3% of its shares in ITC Hotels through an accelerated bookbuild process. The proceeds from this sale will help BAT progress towards its target leverage corridor by the end of 2026. This move is part of BAT’s strategy to optimize its financial position, as the direct stake in ITC Hotels is not considered strategic for the company.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has repurchased 110,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. This transaction, authorized by shareholders, aims to reduce the number of shares in circulation, potentially increasing the value of remaining shares and demonstrating confidence in the company’s financial health.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has announced the repurchase of 115,000 of its ordinary shares as part of its ongoing buyback programme. This transaction, executed through Goldman Sachs International, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The repurchased shares will be canceled, reducing the total number of shares in issue and potentially impacting shareholder voting rights.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 115,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. This transaction, conducted under the authority granted by shareholders, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value. The purchased shares are intended to be canceled, reducing the total number of shares in circulation and potentially impacting the company’s market dynamics and shareholder interests.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced its issued share capital as of November 28, 2025, consisting of 2,181,845,074 ordinary shares with voting rights. The company also holds 132,988,352 shares in treasury. This information is crucial for shareholders to determine their voting rights interest in accordance with the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £49.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 110,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. This transaction, authorized by shareholders, aims to reduce the number of shares in circulation, potentially increasing the value of remaining shares and reflecting the company’s commitment to returning value to shareholders.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £48.50 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a buyback of 110,000 of its ordinary shares at prices ranging from 4,303.00p to 4,343.00p as part of its ongoing share repurchase program. This move, which involves the cancellation of the purchased shares, is expected to impact the company’s share capital structure and could influence shareholder value and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £41.50 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a buyback of 130,000 of its ordinary shares from Goldman Sachs International as part of its ongoing share repurchase program. This transaction, authorized by shareholders, aims to enhance shareholder value by reducing the number of shares in circulation, thereby potentially increasing the value of remaining shares and improving earnings per share.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4639.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the repurchase of 130,000 of its ordinary shares as part of its ongoing buyback program. This transaction, conducted with Goldman Sachs International, reflects the company’s commitment to enhancing shareholder value. The repurchased shares will be canceled, reducing the total number of shares in circulation and potentially increasing the value of remaining shares. This move aligns with the company’s strategic financial management and may impact shareholders’ interests under the FCA’s rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4639.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback, purchasing 129,180 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. The company plans to cancel these shares, which will adjust the number of shares in issue and could impact shareholder interests and voting rights.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £4600.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a transaction involving its Chief Executive, Tadeu Marroco, and Luciana Franco Do Amaral, who is closely associated with him. The transaction involved the acquisition of ordinary shares through the reinvestment of dividend income, with a total value of £7,177.81, conducted on the London Stock Exchange. This move reflects the company’s ongoing financial activities and may impact its market positioning and stakeholder interests.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £4600.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 131,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. This move, authorized by shareholders, is aimed at reducing the number of shares in circulation, potentially increasing the value of remaining shares and consolidating the company’s market position.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £4600.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a buyback of 115,000 of its ordinary shares from Goldman Sachs International, as part of its ongoing share repurchase program. This transaction, authorized by shareholders, aims to reduce the number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder interests under the FCA’s rules.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £4600.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a transaction involving the acquisition of shares by Serpil Timuray, a Non-Executive Director, and Abdurrahman Murat Timuray. This transaction, conducted through the reinvestment of dividend income, involved the purchase of 47 ordinary shares at a price of £42.222415 each, totaling £1,995.19. The transaction took place on November 7, 2025, at the London Stock Exchange. This move reflects the company’s ongoing engagement with its stakeholders and highlights the strategic financial decisions made by its leadership.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £4600.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 138,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. This transaction, authorized by shareholders, is aimed at reducing the number of shares in circulation, potentially increasing the value of remaining shares and enhancing shareholder returns. Following the cancellation of these shares, the company will have 2,182,709,115 ordinary shares in issue, excluding treasury shares, which carry voting rights. This move is part of the company’s strategy to optimize its capital structure and improve its market positioning.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £4600.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the purchase of 115,000 of its own shares as part of a buyback program, with the intention to cancel these shares. This move, executed through Goldman Sachs International, is part of the company’s strategy to manage its capital structure and enhance shareholder value, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £4600.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a transaction involving its Non-Executive Director, Holly Keller Koeppel, who received additional Deferred Stock Units (DSUs) linked to the company’s American Depositary Shares (ADSs). This transaction, which was credited by reference to the value of dividends declared on the ADSs, reflects the company’s ongoing financial strategies and compensation plans, potentially impacting its managerial operations and stakeholder interests.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £4600.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 110,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. The shares, purchased at a volume-weighted average price of 4,257.74 pence, will be canceled, reducing the total number of shares in issue and potentially impacting shareholder interests under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £4600.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 110,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. This move, authorized by shareholders, aims to cancel the purchased shares, thereby reducing the total number of shares in circulation, which may influence shareholder interests and voting rights.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £4600.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced that several of its executives, including the Chief Executive and Chief Operating Officer, have acquired ordinary shares in the company through the reinvestment of dividend income under the British American Tobacco Share Incentive Plan. This move reflects the company’s ongoing commitment to aligning the interests of its management with those of its shareholders, potentially strengthening stakeholder confidence and reinforcing its market position.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced that several of its executives, including the Regional Director for Asia-Pacific, Middle East and Africa, and the Chief Marketing Officer, have acquired ordinary shares through the reinvestment of dividend income. These transactions, conducted on the London Stock Exchange, reflect a strategic move by the company to align its leadership’s interests with shareholder value, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a transaction involving the acquisition of quarterly dividend equivalent shares by its Chief Executive, Tadeu Marroco, under the company’s Deferred Share Bonus Scheme. This transaction, conducted outside a trading venue, reflects the company’s ongoing commitment to rewarding its leadership and could have implications for shareholder value and executive compensation strategies.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 110,000 of its ordinary shares from Goldman Sachs International as part of its ongoing share buyback program. This transaction, authorized by shareholders, reflects the company’s strategy to optimize its capital structure by reducing the number of shares in circulation, potentially enhancing shareholder value and maintaining strong market positioning.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 110,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. The purchased shares will be canceled, reducing the total number of shares in circulation, which may influence shareholder interests and voting rights. This move is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 110,000 ordinary shares as part of its ongoing buyback program, with plans to cancel these shares. This move is in line with the company’s strategy to manage its capital structure and could potentially enhance shareholder value by reducing the number of shares in circulation, thereby increasing earnings per share.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced that several of its executive directors and managerial staff have purchased ordinary shares in the company through the Partnership Share Scheme, a HMRC approved Share Incentive Plan. This move, involving key figures such as the Chief Executive and Chief Marketing Officer, reflects a commitment to align their interests with those of shareholders, potentially strengthening stakeholder confidence and enhancing the company’s market positioning.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a transaction to repurchase 110,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. This move, authorized by shareholders, is aimed at reducing the number of shares in circulation, potentially increasing the value of remaining shares and enhancing shareholder value. The company plans to cancel the repurchased shares, which will affect the total number of shares in issue and may have implications for shareholder notifications under regulatory rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco PLC announced the purchase of 165,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. The company plans to cancel these shares, which will reduce the total number of shares in issue and potentially impact shareholder interests and voting rights. This move is part of the company’s strategic financial management to enhance shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the purchase of 145,000 of its own shares as part of a buyback program, with plans to cancel these shares. This transaction, executed through Goldman Sachs International, reflects the company’s ongoing efforts to manage its share capital and potentially enhance shareholder value, impacting the company’s share structure and market positioning.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced its issued share capital as of October 31, 2025, consisting of over 2.18 billion ordinary shares with voting rights. The company also holds approximately 133 million shares in treasury. This information is crucial for shareholders to determine their voting rights interests in compliance with the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the exercise of its option to redeem €1,000,000,000 worth of perpetual subordinated fixed-to-reset rate non-call 5.25-year securities following a substantial repurchase event. The redemption, set for November 10, 2025, will involve the cancellation of the listing of these securities, impacting the company’s financial structure and potentially influencing its market positioning.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 172,853 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. This move, authorized by shareholders, is aimed at reducing the number of shares in circulation, potentially increasing the value of remaining shares and enhancing shareholder value. Following this transaction, BAT will cancel the purchased shares, resulting in a total of 2,184,030,914 ordinary shares in issue, excluding treasury shares. This strategic financial maneuver may impact the company’s market positioning and shareholder interests.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 173,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. This move, authorized by shareholders, aims to reduce the number of shares in circulation, potentially increasing the value of remaining shares and strengthening the company’s market position.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the final results of its tender offer for its €1 billion Perpetual Subordinated Fixed-to-Reset Rate Non-Call 5.25 Year Securities. The company accepted €806.8 million worth of securities, surpassing the 75% threshold required for a Substantial Repurchase Event Redemption Option. This move is expected to impact the company’s financial strategy and market positioning, as it plans to exercise the redemption option for the remaining securities post-settlement.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 174,000 ordinary shares as part of its ongoing buyback program, which was authorized by shareholders in April 2025. The company plans to cancel these shares, reducing the number of shares in circulation and potentially increasing the value for remaining shareholders. This move is part of a strategic effort to optimize capital structure and enhance shareholder returns.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the publication of a prospectus for the issuance of hybrid capital securities, totaling €1.2 billion, which will be listed on the London Stock Exchange. The proceeds will be used for general corporate purposes, including repurchasing existing securities and repaying debt, potentially strengthening the company’s financial position and market standing.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 174,000 ordinary shares as part of its ongoing buyback program, with the intention to cancel these shares. This transaction, conducted through Goldman Sachs International, reflects the company’s strategy to manage its capital structure and potentially enhance shareholder value by reducing the number of shares in circulation.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco PLC announced the purchase of 177,000 of its own ordinary shares as part of its ongoing buyback program. The shares were acquired from Goldman Sachs International at a volume-weighted average price of 3,867.41 pence per share. Following this transaction, the company plans to cancel the purchased shares, which will affect the total number of shares in issue and those held in treasury. This move is expected to impact the company’s share structure and could influence shareholder decisions regarding their interests in the company.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4056.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 178,453 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. The company intends to cancel these shares, which will impact the total number of shares in issue and those held in treasury, potentially affecting shareholder interests and voting rights.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 179,932 of its ordinary shares from Goldman Sachs International as part of its ongoing share buyback program. This move, authorized by shareholders, is intended to enhance shareholder value by reducing the number of shares in circulation, which may positively impact the company’s stock price and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 179,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. The company plans to cancel these shares, which will adjust the total number of shares in issue and those held in treasury, potentially impacting shareholder interests and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a tender offer for its €1 billion Perpetual Subordinated Fixed-to-Reset Rate Non-Call 5.25 Year Securities. This move is part of the company’s strategy to manage its hybrid capital portfolio proactively. The offer allows security holders to sell their securities ahead of the upcoming redemption date, with the potential for priority allocation in new securities issuance. This initiative reflects the company’s intention to optimize its financial structure and could impact stakeholders by providing liquidity and investment opportunities.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 136,000 of its ordinary shares from Goldman Sachs International as part of its ongoing buyback program. The shares were purchased at prices ranging from 3,798.00p to 3,835.00p and will be cancelled, reducing the total number of shares in issue. This move is part of the company’s strategy to manage its capital structure and return value to shareholders, potentially impacting its share price and market perception.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback program, purchasing 175,000 of its ordinary shares from Goldman Sachs International. This move, authorized by shareholders, aims to reduce the number of shares in circulation, potentially increasing the value for remaining shareholders and strengthening the company’s financial position.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback transaction, purchasing 165,000 of its ordinary shares from Goldman Sachs International. This move, part of a previously announced buyback program, aims to cancel the acquired shares, thereby reducing the total number of shares in circulation and potentially increasing shareholder value. Following this transaction, the company will have 2,185,746,237 ordinary shares in issue, excluding treasury shares, which may impact shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 183,458 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The repurchased shares will be canceled, reducing the total number of shares in circulation, which may impact shareholder interests and the company’s market positioning.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the repurchase of 184,091 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This transaction, authorized by shareholders, aims to reduce the number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder interests. Following this purchase, the company will have 2,186,093,719 ordinary shares in issue, excluding treasury shares, which may influence shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the repurchase of 183,105 of its ordinary shares as part of its ongoing buyback program. This move, executed through Banco Santander, S.A., is intended to cancel the purchased shares, thereby reducing the total number of shares in circulation. The transaction reflects the company’s strategy to enhance shareholder value and manage its capital structure effectively.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the appointment of Matthew Wright as an independent Non-Executive Director, effective from November 1, 2025. Wright’s extensive experience in advising global organizations on talent management and transformation is expected to support BAT’s ongoing cultural transformation and growth initiatives, particularly as the company pursues its ambition to create a Smokeless World.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback transaction, purchasing 182,594 of its ordinary shares from Banco Santander, S.A. as part of its ongoing buyback program. This move, approved by shareholders, aims to enhance shareholder value by reducing the number of shares in circulation. Following the cancellation of these shares, the company will have 2,186,460,572 ordinary shares in issue, excluding treasury shares, which may impact shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. has executed a share buyback program, purchasing 182,132 of its ordinary shares from Banco Santander, S.A. The company plans to cancel these shares, reducing the total number of shares in circulation, which may influence shareholder interests and voting rights. This move is part of a broader strategy to manage its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced a share buyback program, commencing on 16 October 2025 and concluding on 23 December 2025, in collaboration with Goldman Sachs International. The initiative aims to reduce the company’s share capital by repurchasing and canceling up to 220,451,469 shares, as authorized by shareholders at the 2025 AGM, adhering to specific regulatory frameworks and pricing conditions.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 182,086 of its ordinary shares from Banco Santander as part of its ongoing share buyback program. This transaction, which was conducted under the authority granted by shareholders, aims to cancel the purchased shares, thereby reducing the number of shares in circulation and potentially increasing shareholder value. Following this buyback, the company will have 2,186,823,998 ordinary shares in issue, excluding treasury shares, which may impact shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced the purchase of 184,025 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This move, authorized by shareholders, is part of the company’s strategy to manage its capital structure and enhance shareholder value. The purchased shares will be canceled, reducing the total number of shares in circulation, which could impact shareholder voting rights and interest notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has executed a share buyback transaction, purchasing 182,423 of its ordinary shares from Banco Santander as part of its ongoing buyback program. The company intends to cancel these shares, which will adjust its total number of shares in issue and those held in treasury. This move is likely to impact shareholder interests and aligns with regulatory transparency requirements.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase and cancellation of 182,160 of its ordinary shares as part of its ongoing share buyback program. This transaction, conducted with Banco Santander, S.A., is part of the company’s strategy to optimize its capital structure and deliver value to shareholders. Following this buyback, the company has 2,187,372,221 ordinary shares in issue, excluding treasury shares, which carry voting rights. This move is expected to impact the company’s share capital and may influence shareholder notifications under regulatory guidelines.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £4004.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced that several of its executives, including the Chief Executive and Chief Marketing Officer, have purchased ordinary shares in the company through the Partnership Share Scheme, a HMRC approved Share Incentive Plan. This move reflects a commitment to align the interests of the company’s leadership with those of its shareholders, potentially impacting the company’s market perception and stakeholder confidence.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £44.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 126,705 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This move, authorized by shareholders, aims to cancel the purchased shares, thereby reducing the total number of shares in circulation and potentially increasing shareholder value. Following this transaction, the company will have 2,187,554,381 ordinary shares in issue, excluding treasury shares, which could impact shareholders’ interests and voting rights.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £44.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco has announced its issued share capital as of 30 September 2025, which consists of over 2.18 billion ordinary shares with voting rights. This information is crucial for shareholders to determine their voting rights interest under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:BATS) stock is a Buy with a £44.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco announced the purchase of 126,462 of its ordinary shares from Banco Santander as part of its ongoing buyback program. This transaction, authorized by shareholders, aims to cancel the acquired shares, reducing the total number of shares in circulation and potentially enhancing shareholder value. The buyback reflects the company’s strategic financial management and could impact stakeholders by altering shareholding percentages.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £34.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
British American Tobacco p.l.c. announced the purchase of 126,658 of its ordinary shares from Banco Santander, S.A. as part of its ongoing buyback program. This transaction, authorized by shareholders and aimed at reducing the number of shares in circulation, reflects the company’s strategy to enhance shareholder value and optimize its capital structure.
The most recent analyst rating on (GB:BATS) stock is a Sell with a £34.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.